Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies

2014-11-05 01:27:39 | BioPortfolio

Published on BioPortfolio: 2014-11-05T01:27:39-0500

Clinical Trials [249 Associated Clinical Trials listed on BioPortfolio]

A Study to Evaluate the Safety and Pharmacokinetics of SAR650984 in Patients With Multiple Myeloma

Primary Objective: To evaluate the safety of SAR650984 in patients with relapsed/refractory multiple myeloma (RRMM). Secondary Objective: To determine the pharmacokinetics (...

SAR650984 Combined to CyBorD in Newly Diagnosed Multiple Myeloma (MM) Non Eligible for Transplant

Primary Objective: To determine the maximum tolerated dose (MTD) and recommended dose (RD) of SAR650984 when administered in combination with bortezomib, cyclophosphamide, and dexamethaso...

SAR650984, Pomalidomide and Dexamethasone in Combination in RRMM Patients

Primary Objective: Safety Secondary Objective: Efficacy, Pharmacokinetics (PK)

Clinical Implications of Azole-Resistant Aspergillosis in Hematological Malignancy

In order to determine the efficacy of antifungal therapy in patients with documented azole-resistant invasive Aspergillosis (IA), anonymized clinical information of patients with a hematol...

A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy

The purpose of this study is to determine the safety and anti-tumor effects of an experimental immunotherapy drug, called AlloStim, which is intentionally mis-matched immune cells which ar...

PubMed Articles [1126 Associated PubMed Articles listed on BioPortfolio]

Drug approval based on randomized phase 3 trials for relapsed malignancy: analysis of oncologic drugs granted accelerated approval, publications and clinical trial databases.

Background As relapsed disease is frequently the first target of newly developed therapies, it is vital to address the difficulty in demonstrating the efficacy of new drugs for relapsed malignancy in ...

Hematological Analysis in Thai Samples With Deletional and Nondeletional HbH Diseases.

To compare hematological parameters between deletional and nondeletional HbH diseases, and to investigate the correlation between HbH levels and hematological parameters within these 2 groups.

Delayed Socket Healing After Dental Extraction in Patients Undergoing Myelosuppressive Chemotherapy for Hematological Malignancy: Incidence and Risk Factors.

The purpose of this study was to measure the frequency and identify factors associated with delayed socket healing after dental extraction in patients undergoing myelosuppressive chemotherapy for hema...

What the internist should know about stem cell transplant in the elderly patient.

Most hematological malignancies are increasing in frequency with age. Allogeneic hematopoietic cell transplantation (allo-HCT) is a potentially curative therapeutic option for patients with malignant ...

Dose-response relationship between blood lead levels and hematological parameters in children from central China.

Lead is a heavy metal that can affect the human hematological system. However, reports are limited on the dose-response relationship between blood lead levels (BLLs) and hematological parameters in ch...

Medical and Biotech [MESH] Definitions

Use of HIRUDINS as an anticoagulant in the treatment of cardiological and hematological disorders.

A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.

A genus in the family HERPESVIRIDAE, subfamily ALPHAHERPESVIRINAE, associated with malignancy in birds.

A condition caused by a brief whole body exposure to more than one sievert dose equivalent of radiation. Acute radiation syndrome is initially characterized by ANOREXIA; NAUSEA; VOMITING; but can progress to hematological, gastrointestinal, neurological, pulmonary, and other major organ dysfunction.

Abnormal protrusion of both eyes; may be caused by endocrine gland malfunction, malignancy, injury, or paralysis of the extrinsic muscles of the eye.

More From BioPortfolio on "Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies"

Quick Search


Searches Linking to this Trial